KLIFO A/S
CVR 18196131 · Public limited company (A/S) · Active · Low risk
KLIFO A/S is a Public limited company (A/S), founded on , based in Brøndby. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 16.1m and a net result of DKK -47.4m. CEO: René Holmen Pedersen.
Bankruptcy risk for KLIFO A/S
0.0 × the average (1.41%) · higher risk than 18% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 18196131
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (31 years)
- Address
- Abildager 24
2605 Brøndby - Municipality
- Brøndby
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 625k
- Employees
- 83 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 31 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 15.9% |
| Current ratio | 61% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 6 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 0 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 84.1m | DKK 101.4m | DKK 104.6m |
| Net profit | DKK -47.4m | DKK -128k | DKK 5.9m |
| Equity | DKK 16.1m | DKK 48.5m | DKK 33.7m |
| Total assets | DKK 101.3m | DKK 97.8m | DKK 92.6m |
| Cash | DKK 4.8m | DKK 7.9m | – |
| Short-term debt | DKK 48.4m | DKK 39.9m | – |
| Tax owed | – | DKK 0 | – |
| Avg. employees | 118 | 122 | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Independent Auditor’s Report · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 180 | ||
| 1 Jan 2024 – 31 Dec 2024 | 136 | ||
| 1 Jan 2023 – 31 Dec 2023 | 123 | ||
| 1 Jan 2022 – 31 Dec 2022 | 167 | ||
| 1 Jan 2021 – 31 Dec 2021 | 151 | ||
| 1 Jan 2020 – 31 Dec 2020 | 97 | ||
| 1 Jan 2019 – 31 Dec 2019 | 93 | ||
| 1 Jan 2018 – 31 Dec 2018 | 99 | ||
| 1 Jan 2017 – 31 Dec 2017 | 99 | ||
| 1 Jan 2016 – 31 Dec 2016 | 72 | ||
| 1 Jan 2015 – 31 Dec 2015 | 109 | ||
| 1 Jan 2014 – 31 Dec 2014 | 97 | ||
| 1 Jan 2013 – 31 Dec 2013 | 112 | ||
| 1 Jan 2012 – 31 Dec 2012 | 123 | ||
| 1 Jan 2011 – 31 Dec 2011 | 142 | ||
| 1 Jan 2010 – 31 Dec 2010 | 145 | ||
| 1 Jan 2009 – 31 Dec 2009 | 159 | ||
| 1 Jan 2008 – 31 Dec 2008 | 148 | ||
| 1 Jan 2007 – 31 Dec 2007 | 147 | ||
| 1 Jan 2006 – 31 Dec 2006 | 81 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | René Holmen Pedersen | Current | |
| CEO | Allan Rosetzsky | ||
| CEO | Alejandra Maria Cristina Bonifacini Mørk | ||
| CEO | Rasmus Koch Nelund | ||
| Board | Redmar Koene | Current | |
| Board | Niels Peder Nielsen | Current | |
| Board | Alejandra Maria Cristina Bonifacini Mørk | Current | |
| Board | Rafael Natanek | Current | |
| Board | Ole Ingemann Olsen | ||
| Board | Torben Moltke-Leth | ||
| Board | Allan Rosetzsky | ||
| Board | Kim Arthur Hueg | ||
| Board | Ahrnt Clausen | ||
| Board | Mette Kirstine Agger | ||
| Board | Claes-Erik Wilhelmsson | ||
| Board | Thor-Björn Gunnar Conradsson | ||
| Board | Jonas Ekblom | ||
| Board | Morten Nielsen | ||
| Board | Alejandra Maria Cristina Bonifacini Mørk | ||
| Board | Kerstin B Valinder Strinnholm | ||
| Board | Kerstin Valinder Strinnholm | ||
| Board | Dorte Bregnhøj | ||
| Board | Mette Kirstine Agger | ||
| Board | Rafael Natanek | ||
| Owner (100%) | Drug Development Consulting BidCo ApS | Current | |
| Owner (100%) | HERON HOLDING A/S | ||
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | EJENDOMSSELSKABET KLÆDEMÅLET A/S | ||
| Auditor | CR ÅR 2001 A/S | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | HORWATH REVISORERNE STATSAUTORISERET REVISIONSINTERESSENTSKAB | ||
| Auditor | CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB | ||
| Founder | Ole Ingemann Olsen | Current | |
| Founder | Allan Rosetzsky | Current |
The CEOs' other companies
René Holmen Pedersen – 3 other companies
- Drug Development Consulting BidCo ApS Active
- Drug Development Consulting Holding ApS Active
- TFS TRIAL FORM SUPPORT ApS Active
Allan Rosetzsky – 9 other companies, of which 2 bankrupt
- AFVIKLINGSSELSKABET AF 8.2.1999 A/S Bankrupt 6 Jul 2000
- INTERFACE BIOTECH A/S Bankrupt 11 Mar 2010
- AR CONSULT ApS Active
- AdaptVac ApS Active
- EXPRES2ION BIOTECHNOLOGIES ApS Active
- GlyProVac ApS Active
- Hepoligo Solutions ApS Opløst
- ROSETZSKY A/S Opløst
- WIOTECH DEVICES A/S Opløst
Alejandra Maria Cristina Bonifacini Mørk – 11 other companies
- DDC Mørk Holding ApS Active
- Drug Development Consulting BidCo ApS Active
- Drug Development Consulting Holding ApS Active
- Epoqe Pharma ApS Active
- HERON HOLDING A/S Opløst
- Life Science Legal ApS Active
- Loma Therapeutics ApS Active
- Mørk Consulting ApS Active
- Phillips-Medisize A/S Active
- Scandion Oncology A/S Opløst
- TAKEDA PHARMA A/S Active
Rasmus Koch Nelund – 10 other companies, of which 2 bankrupt
- PIPELINE BIOTECH A/S Bankrupt 31 May 2016
- RR Blockchain Operations ApS Bankrupt 30 Nov 2022
- ADDICO ApS Compulsorily dissolved
- ANSN ApS Active
- CAVEO ApS Compulsorily dissolved
- Drug Development Consulting BidCo ApS Active
- Drug Development Consulting Holding ApS Active
- HERAX METHODS A/S Opløst
- Life Sciences Advisory ApS Active
- PASSION & DISCIPLINE ApS Active
Address history (2 moves)
| Abildager 24, 2605 Brøndby | |
| Smedeland 36, 2600 Glostrup | |
| c/o Københavns Forskerby, Fruebjergvej 3, 2100 København Ø |
Employees per year
Similar companies in Brøndby
- Tantiloy ApS Brøndby
- Greenwood Data Mining ApS Brøndby
- Second Sun APS Brøndby
- MotorSkills Hockey ApS Brøndby Strand
- PS Invest 2017 ApS Brøndby
- DRYBOOTS IVS Brøndby
- B-WARE ApS Brøndby
- PAS TECHNOLOGY A/S Brøndby
Questions and answers about KLIFO A/S
Has KLIFO A/S gone bankrupt?
No, KLIFO A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of KLIFO A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of KLIFO A/S?
René Holmen Pedersen is the CEO of KLIFO A/S.
Who is the auditor of KLIFO A/S?
KLIFO A/S most recently used EY Godkendt Revisionspartnerselskab.
When was KLIFO A/S founded?
KLIFO A/S was founded on 15 November 1994.
What is the equity of KLIFO A/S?
Equity was DKK 16.1m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.